Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 2,255,996	$ 3,264,429
Accounts receivable	189,597	110,574
Prepaid expenses	474,468	338,660
Other current assets	343,246	343,145
Total Current Assets	3,263,307	4,056,808
Property and equipment, net	4,500,065	4,429,152
Operating lease right-of-use assets	635,041	599,816
Intangible assets, net	306,377	313,747
Total Assets	8,704,790	9,399,523
Current Liabilities
Accounts payable	2,351,261	2,766,178
Accrued liabilities	4,389,312	3,476,903
Deferred revenue	122,441	230,000
Management and directors' fees payable	54,392	30,086
Current portion of long-term debt	1,017,348	860,223
Current portion of finance lease liabilities	53,842	46,737
Current portion of operating lease liabilities	252,013	221,755
Current portion of grant repayable	69,345	60,979
Warrant liability	140,612	97,886
Derivative liability	623,790	0
Current portion of convertible note payable, net	166,522	0
Total Current Liabilities	9,240,878	7,790,747
Deferred revenue, net of current portion	22,663,400	22,663,400
Long-term debt, net of current portion	5,771,375	3,952,846
Finance lease liabilities, net of current portion	346,291	328,338
Operating lease liabilities, net of current portion	417,015	410,686
Grant repayable, net of current portion	443,911	361,242
Convertible note payable, net of current portion	2,920,242	0
Total Long-Term Liabilities	32,562,234	27,716,512
Total Liabilities	41,803,112	35,507,259
Stockholders' Deficit
Common Stock Authorized: 325,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 103,982,020 shares and 96,097,485 shares, respectively	103,982	96,098
Additional paid-in capital	209,777,146	204,154,994
Accumulated other comprehensive income	(444,294)	385,631
Accumulated deficit	(241,252,180)	(229,544,343)
Total VolitionRx limited Stockholders' Deficit	(31,815,346)	(24,907,620)
Non-controlling interest	(1,282,976)	(1,200,116)
Total Stockholders' Deficit	(33,098,322)	(26,107,736)
Total Liabilities and Stockholders' Deficit	$ 8,704,790	$ 9,399,523